I agree sdj. was hoping for around 500k in receipts so a little disappointed, but can see us hitting the 2-3m mark for the one product in the next couple of quarterlies.we also have 4 more (hopefully 5) new products in the pipeline. with better royalties we can expect equal or better returns from each. 2 of the new products are expected to be released next year, but how long for the 2, that have been in development before last months Ann. maybe sometime this year?
- Forums
- ASX - By Stock
- WFL
- Ann: Appendix 4C June 2018 Quarter
Ann: Appendix 4C June 2018 Quarter, page-57
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online